glp 1 and hormone replacement GLP-1s Therapy: Can You Take Them Together? Bioidentical Hormone Replacement Therapy |

Peripheral artery disease (PAD) is a circulatory problem that limits blood flow to the extremities

Not the door shelf where temperatures fluctuate every time you open the fridge

doi: 10.1038/s42255-022-00591-z 9 de SousaRTZarateCAJrZanettiMVCostaACTalibLLGattazWFet al

Escalation schedules

Tirzepatide (MOUNJARO) Pronounced: tir ZEP a tide / mown JAHR OH Mnemonic: Tear zeppelin (over) Mount (Kiliman)jaro Year of release: 2022 Cost: $1060 / mo FDA-approved for: Type 2 diabetes Mechanism: dual GLP-1/GIP receptor agonist Available doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg (weekly subcutaneous injection) Dynamic interactions: Glucose lowering Kinetic interactions: Delayed gastric emptying, otherwise none significant in a bubble Tirzepatide (Mounjaro) is the first twincretin for type 2 diabetes

We believe that considering multiple lives of evidence is necessary given the complexities particular to this topic